KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Liabilities and Shareholders Equity (2016 - 2025)

Cvs Health (CVS) has disclosed Liabilities and Shareholders Equity for 17 consecutive years, with $253.5 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Liabilities and Shareholders Equity changed 0.13% year-over-year to $253.5 billion, compared with a TTM value of $1022.8 billion through Dec 2025, up 1.48%, and an annual FY2025 reading of $253.5 billion, changed 0.13% over the prior year.
  • Liabilities and Shareholders Equity was $253.5 billion for Q4 2025 at Cvs Health, down from $255.3 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $258.3 billion in Q2 2025 and bottomed at $228.3 billion in Q4 2022.
  • Average Liabilities and Shareholders Equity over 5 years is $244.3 billion, with a median of $249.7 billion recorded in 2024.
  • The sharpest move saw Liabilities and Shareholders Equity dropped 2.03% in 2022, then grew 9.4% in 2023.
  • Year by year, Liabilities and Shareholders Equity stood at $233.0 billion in 2021, then fell by 2.03% to $228.3 billion in 2022, then grew by 9.4% to $249.7 billion in 2023, then rose by 1.4% to $253.2 billion in 2024, then rose by 0.13% to $253.5 billion in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for CVS at $253.5 billion in Q4 2025, $255.3 billion in Q3 2025, and $258.3 billion in Q2 2025.